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Arf family history: Arfs, Arls, SARs, 
and other members
Arfs. Arf was fi  rst discovered, purifi  ed, and functionally de-
fi  ned as the protein cofactor required for cholera toxin–catalyzed 
ADP ribosylation of the stimulatory regulatory subunit (Gs) of 
adenylyl cyclase (Enomoto and Gill, 1980; Kahn and Gilman, 
1984) and, shortly thereafter, was shown to be a GTP-binding 
protein (Kahn and Gilman, 1986). Use of the acronym Arf is 
currently preferred to ADP ribosylation factor, as only Arf1–6 
shares the cofactor activity for cholera toxin and because ADP 
ribosylation does not appear to be involved in any aspect of the 
normal cellular actions of any member of the family. The use of 
all capital letters (e.g., ARF1) refers specifi  cally to the human 
gene or protein, whereas when only the fi  rst letter is capitalized 
(e.g., Arf1), it may refer to the protein from more than one spe-
cies, an activity, or a group of proteins. Since their discovery, 
they have been found to be ubiquitous regulators of membrane 
traffi  c and phospholipid metabolism in eukaryotic cells (for re-
views and discussion of Arf actions see Nie et al., 2003; Burd 
et al., 2004; Kahn, 2004). Arfs are soluble proteins that translocate 
onto membranes in concert with their activation, or GTP bind-
ing. The biological actions of Arfs are thought to occur on mem-
branes and to result from their specifi  c interactions with a large 
number of effectors that include coat complexes (COPI, AP-1, 
and AP-3), adaptor proteins (GGA1-3 and MINT1-3/X11α-γ/
APBA1-3), lipid-modifying enzymes (PLD1, phosphatidylino-
sitol (4,5)-kinase, and phosphatidylinositol (4)-kinase), and oth-
ers. Arf proteins are activated by guanosine diphosphate (GDP) 
to GTP exchange, which is stimulated by the Sec7 domain of Arf 
guanine nucleotide exchange factors, and their activity is termi-
nated upon the hydrolysis of GTP, which is stimulated by inter-
action with an Arf GTPase-activating protein.
Cloning and sequencing of the fi  rst Arf family member 
(Sewell and Kahn, 1988) led directly to the realization that 
Arfs are closely related to both the Ras and heterotrimeric 
G protein α subunit families of GTPases, and all are thought to 
have arisen from a common ancestor. The very high degree of 
conservation of Arf sequences in eukaryotes (74% between 
human and yeast) was also noted early on and has allowed the 
ready identifi  cation of orthologues in every examined eukary-
ote, including Giardia lamblia, which lack Ras and G protein 
α subunits (Murtagh et al., 1992).
Cloning by low stringency hybridization and chance led 
to the identifi  cation of additional members of the Arf family in 
a wide array of eukaryotic species. The number of mammalian 
Arfs grew to six by 1992 (Tsuchiya et al., 1991) and were named 
in their order of discovery (Price et al., 1988; Bobak et al., 1989; 
Kahn et al., 1991; Lee et al., 1992). The fi  rst confusion in the 
nomenclature was that the current human ARF4 was originally 
published with the name ARF2 (Kahn, et al., 1991). In fact, hu-
mans appear to have lost the ARF2 orthologue, which is present 
in other mammals (including rats, mice, and cows). The combi-
nation of protein sequence comparisons and intron/exon bound-
aries of Arf genes led to further classifi   cation of the six 
mammalian Arfs into classes: class I (ARF1–3 are >96% iden-
tical), class II (ARF4 and ARF5 are 90% identical to each other 
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The Ras superfamily is comprised of at least four large 
families of regulatory guanosine triphosphate–binding 
proteins, including the Arfs. The Arf family includes three 
different groups of proteins: the Arfs, Arf-like (Arls), and 
SARs. Several Arf family members have been very highly 
conserved throughout eukaryotic evolution and have 
orthologues in evolutionally diverse species. The different 
means by which Arf family members have been identiﬁ  ed 
have resulted in an inconsistent and confusing array of 
names. This confusion is further compounded by differ-
ences in nomenclature between different species. We 
propose a more consistent nomenclature for the human 
mem    bers of the Arf family that may also serve as a guide 
for nomenclature in other species.
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and 80% identical to the other Arfs), and class III (ARF6 is 64–
69% identical to the other Arfs). Phylogenetic analyses support 
the conclusion that the three classes of Arf diverged early, as 
fl  ies and worms have single representatives of each of the three 
classes, and the number of genes/proteins in class I and II were 
later expanded in vertebrates.
Arls. The initial criteria for naming new Arfs were func-
tional, and only those proteins that could (1) serve as cofactors 
for cholera toxin, (2) rescue the lethal arf1
−arf2
− deletion in 
Saccharomyces cerevisiae, and (3) directly activate PLD were 
given the name Arf. Thus, with the chance cloning of an essential 
gene in Drosophila melanogaster that encoded a protein closely 
related to the Arfs (50–60% identity) but lacking in these activ-
ities, it was named arfl  ike (Tamkun et al., 1991). When ortho-
logues were found in several other species, the name was changed 
to Arf-like 1 (ARL1) in those species (Kahn et al., 1992; Breiner 
et al., 1996; Lowe et al., 1996). Note that although the name Arf 
still denotes a protein with one or more specifi  c functions or ac-
tivities, the term Arl does not. The term Arl indicates only that 
the protein is structurally related to Arfs. Thus, the Arls are not a 
coherent group either functionally or phylogenetically.
PCR amplifi  cation with degenerate oligonucleotide prim-
ers (Clark et al., 1993; Schurmann et al., 1994) revealed the ex-
istence of a large number of mammalian cDNAs encoding 
closely related proteins. The next to be cloned and sequenced 
were ARL2 (Clark et al., 1993), ARL3 (Cavenagh et al., 1994), 
ARL4 (Schurmann et al., 1994), and ARL5 (Breiner et al., 1996). 
Each of the encoded proteins has a glycine at position 2, the site 
of  N-myristoylation in all Arf proteins. Note that although 
ARL2 and ARL3 have the NH2-terminal glycine, they appear 
not to be substrates for N-myristoyltransferases.
Around this time, a protein with similar percent identities 
to the Arf and Arls was found, but it lacked the NH2-terminal 
glycine, was membrane associated, and displayed distinctive 
nucleotide handling properties (Schurmann et al., 1995). Thus, 
it was given the name Arf-related protein 1 (ARFRP1) to distin-
guish it from the Arls and Arfs. We realize today that this was 
unfortunate, as several of the more recently identifi  ed Arls also 
have functions and biochemical properties that are quite diver-
gent from Arfs.
SARs. SAR1 was among the earliest members of the 
Arf family sequenced, and it came out of genetic screens in the 
yeast S. cerevisiae as a suppressor of sec12(ts) (Nakano and 
Muramatsu, 1989). Its name is derived from its identifi  cation as 
a secretion-associated and Ras-related protein. Cloning of the 
mammalian orthologues revealed the presence of two closely 
related (90% identity) proteins/genes (Kuge et al., 1994). With 
<30% identity to Arfs or Arls, the SAR proteins are only 
slightly closer in sequence to Arfs than to other families of 
GTPases, but they also share considerable functional relatedness 
to Arfs in that they act through the recruitment of coat proteins 
or complexes to initiate vesicle budding. SARs lack the other 
aforementioned Arf activities.
Additional domains. An interesting variation is 
found in ARD1/tripartite motif 23 (TRIM23), a 64-kD protein 
that possesses a  20-kD domain at its COOH terminus with 60% 
identity to Arfs (Mishima et al., 1993). Originally named based 
on the presence of the Arf domain, ARD1 is also a member of the 
TRIM family, from which it obtained its current name, TRIM23. 
A large extension is also seen in ARL13B, a protein of 428 res-
idues that contains an Arl domain at its NH2 terminus (Chiang 
et al., 2004; Fan et al., 2004). Although the NH2-terminal portion 
of TRIM23 may possess GTPase-activating protein activity to-
ward its own Arf domain (Vitale et al., 1996) and E3 ubiquitin 
ligase activity (Vichi et al., 2005), the COOH-terminal portion of 
ARL13B has no defi  ned domains or functions to date.
Deﬁ  ning the Arf family
As the discussion above suggests, there are no shared functions 
or activities that justify grouping Arf, Arl, and SAR proteins 
into a family with a common nomenclature. Similarities in pro-
tein sequences within the Arf family were fi  rst identifi  ed by 
alignment and phylogenetic analyses and were shown to pro-
vide distinct signatures that allowed differentiation from Ras, 
G protein α subunits, and other GTPases. These include an NH2-
terminal extension, a glycine acceptor for myristate at position 2, 
an aspartate at position 26 (in contrast to the glycine 12 of Ras 
that carries oncogenic potential), and other residues that are 
very highly conserved within the family. These early observa-
tions were put on more solid functional footing when they were 
found to map to unique elements in their three-dimensional 
structures, which allow for the GDP/GTP switch to be coupled 
with interaction signals opposite to the nucleotide-binding site 
(for review see Pasqualato et al., 2002). The prominent feature 
of this unique nucleotide switch is a nonconventional GDP-
bound form in which the two β strands that connect the  nucleotide-
sensitive switch 1 and 2 regions (also called the interswitch) are 
retracted in the protein core and must undergo a two-residue 
shift to reach the active conformation (Fig. 1).  However, the in-
terswitch cannot do so unless the NH2-terminal helical exten-
sion, which caps the interswitch and locks it in the retracted 
conformation, has been displaced. In the case of ARF1, bio-
chemical studies have established that this requires the interac-
tion of the NH2 terminus with membranes, thus allowing the 
nucleotide-binding site to detect and respond to remote 
protein–membrane interactions (Antonny et al., 1997). Like 
Arf proteins, each Sar has an NH2-terminal amphipathic helix 
that functions as a structural GDP/GTP switch to anchor the 
GTP-bound form to membranes of the endoplasmic reticulum 
(Huang et al., 2001; Bi et al., 2002). Furthermore, membrane 
insertion of this NH2-terminal helix was recently shown to initi-
ate membrane bending at the early stages of COPII coat assem-
bly and to be subsequently required for the completion of COPII 
vesicle fi  ssion (Lee et al., 2005).
Structural analysis of ARF1 and ARF6 GDP/GTP cycles 
and their comparison with those of small GTP-binding proteins 
whose interswitch does not toggle identifi  ed three structural de-
terminants for this movement: a helical NH2-terminal extension 
that fastens the retracted, GDP-bound interswitch; a shorter in-
terswitch that can retract completely; and a sequence signature 
(wDvGGqXXXRxxW) that provides both fl  exibility  for  the 
movement (GG) and hydrogen bonds for stabilization of the ac-
tive conformation (R/W). These characteristics are   present in all 
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have the ability to undergo the interswitch toggle to detect inter-
actions opposite to the nucleotide-binding site, whatever their 
nature, and propagate them to this site (Pasqualato et al., 2002).
These structural criteria for unifying Arf and Arl proteins 
as a family have since been supported by various structures of 
GDP-bound Arf and Arl proteins (Table S1, available at http:// 
www. jcb. org/ cgi/ content/ full/ jcb. 200512057/ DC1).  It should 
be noted, however, that one subgroup, ARL4, has a long inter-
switch that may have lost the ability to toggle, whereas struc-
tures of NH2-terminally truncated ARL8A and ARL8B bound 
to GDP have a GTP-like conformation. This suggests that trun-
cation of the NH2 terminus is suffi  cient in this family to destabi-
lize the retracted interswitch or that these proteins have lost 
their ability to undergo the interswitch toggle. Recent work on 
ARL3 suggests that proteins interacting with the NH2 terminus 
could also work as the displacing factor as an alternative to 
membranes (Behnia et al., 2004; Setty et al., 2004).
Arf family nomenclature
Table I contains information on proposed and previous names 
as well as other information on the human ARF family members.   
EST and genomic sequencing resulted in the identifi  cation of 
subsequent Arf-like proteins, and these proteins/genes were of-
ten misnamed or named multiple times by different research 
groups. Some of these names suggest relationships that are mis-
leading, and some are called Arfs despite (presumably) lacking 
any Arf activities. In many cases, no functional data are yet 
available for the most recently identifi  ed Arf family members. 
One protein has been referred to by four different names, and 
some proteins/genes were named by curators of databases re-
sponding to specifi  c requests in a manner that disagreed with 
common usage by researchers in the fi  eld. The confusion is 
magnifi  ed when species differences are considered (e.g., yeast 
Arl3 is the orthologue of ARFRP1).
The need for a generally agreed upon nomenclature for 
the ARF family has become acute as a result of increasing 
  confusion and interest in their study. It is not possible today to 
propose a completely consistent nomenclature, as there are   simply 
too many studies with some of the earlier discovered proteins 
(e.g., ARFRP1 should be an ARL).
The nomenclature developed and described in this article 
builds on previous efforts to describe phylogenetic relationships 
and bring consistency to nomenclature (Pasqualato et al., 2002; 
Li et al., 2004; Logsdon and Kahn, 2004). It is the result 
of many discussions between researchers in the fi  eld and with 
the HUGO Genome Nomenclature Committee (HGNC) and has 
been widely circulated to Arf family researchers. We describe 
the presence in the human proteome of 29 members of the Arf 
family and a system for naming newly identifi  ed proteins in hu-
man or other species. The use of letter suffi  xes is reserved for 
those groups of proteins within the family that share higher per-
cent identities and are, therefore, likely to share some level of 
functional redundancy. One exception to this is the ARL13A 
and ARL13B proteins, which have been given a common num-
ber based upon phylogenetic evidence. The consensus nomen-
clature for the Arf family is shown in Table I along with previous 
names and unique gene/protein identifying information. Note 
that in three cases (ARL5C, ARL9, and ARL16), the intron/exon 
boundary predictions in the database are thought to be incorrect 
(based upon comparisons with sequences in other species), 
resulting in differences in the predicted protein sequences. 
In these cases, we use our corrected sequences for comparisons 
and provide the predicted protein sequences of the human pro-
teins (see supplemental material, available at http:// www. jcb. 
org/ cgi/ content/ full/ jcb. 200512057/ DC1).  In addition, there is 
one case (ARL9) in which it appears that alternative splicing 
yields two different proteins, one of which is truncated and pre-
dicted to be unable to bind nucleotides, so both are provided in 
the supplemental protein sequence material.
We also identify several gene sequences that have ques-
tionable EST/mRNA support and are likely pseudogenes 
derived from members of the Arf family. These genes, which 
are annotated by the HGNC, are therefore not included as Arf 
family members and are listed, along with their identifi  ers, in 
Figure 1.  The structural “air de famille.” In Arfs, 
Arls, and SAR proteins, the interswitch toggles 
from an unusual retracted conformation in the 
GDP-bound form that is fastened by the NH2-
terminal helix to an exposed conformation in 
the GTP-bound form that is stabilized by the 
W/GG/R signature (shown here for ARF6-
GDP and ARF6-GTP). This large conforma-
tional change, which involves a two-residue 
β-strand register shift in the core of the G domain, 
allows the nucleotide-binding site to detect 
remote interactions taking place at the NH2 
terminus (reproduced from Pasqualato et al., 
2001 with permission).JCB • VOLUME 172 • NUMBER 5 • 2006 648
Table I. The Arf family GTPases: summary of names, identiﬁ  ers, and NH2-terminal sequences
Accepted 
symbols
Proposed new names Previous 
HGNC 
symbol
Former 
common 
name
Other names 
or information
Accession number
(protein)
Length 
(aa)
NH2-terminal 
sequence
Gene 
locus 
ID
Human 
locus
ARF1 ARF1 ARF1 NP_001649 181 M  G  N  I  F  A  N  L  F  K  G  L 375 1q42
ARF3 ARF3 ARF3 NP_001650 181 M  G  N  I  F  G  N  L  L  K  S  L 377 12q13
ARF4 ARF4 ARF4 NP_001651 180 M  G  L  T  I  S  S  L  F  S  R  L 378 3p21.2-p21.1
ARF5 ARF5 ARF5 NP_001653 180 M  G  L  T  V  S  A  L  F  S  R  I 381 7q31.3
ARF6 ARF6 ARF6 NP_001654 175 M  G  K  V  L  S  K  I  F  G  N  K 382 14q21.3
ARL1 ARL1 ARL1 ARFL1 NP_001168 181 M  G  G  F  F  S  S  I  F  S  S  L 400 7q13
ARL2 ARL2 ARL2 ARFL2 NP_001658 184 M  G  L  L  T  I  L  K  K  M  K  Q 402 11q13
ARL3 ARL3 ARL3 ARFL3 NP_004302 182 M  G  L  L  S  I  L  R  K  L  K  S 403 10q23.3
ARL4A
b ADP ribosylation factorlike 4A ARL4
c ARL4 NP_005729 200 M  G  N  G  L  S  D  Q  T  S  I  L 10124 7p21-p15.3
ARL4C
b ADP ribosylation factorlike 4C ARL7
c ARL7 LAK NP_005728 192 M  G  N  I  S  S  N  I  S  A  F  Q 10123 2q37.1
ARL4D
b ADP ribosylation factorlike 4D ARF4L
c ARL9 ARL6/ARF4L/ 
ARL5/ARL4L
NP_001652 201 M  G  N  H  L  T  E  M  A  P  T  A 379 17q12-q21
ARL5A
b ADP ribosylation factorlike 5A ARL5
c ARL5 NP_036229 179 M  G  I  L  F  T  R  I  W  R  L  F 26225 2q23.3
ARL5B
b ADP ribosylation factorlike 5B ARL8
c ARL5B ARL8/similar to 
ARL5/ARL5-like
NP_848930 179 M  G  L  I  F  A  K  L  W  S  L  F 221079 10p12.31
ARL5C
b ADP ribosylation factorlike 5C ARL12
c ARL12 XP_372668 179
a M  G  Q  L  I  A  K  L  M  S  I  F 390790 17q12
ARL6 ARL6 ARL6 BBS3 NP_115522 186 M  G  L  L  D  R  L  S  V  L  L  G 84100 3q11.2
ARL8A
b ADP ribosylation factorlike 8A ARL10B
c ARL8A ARL10B/GIE2 NP_620150 186 M  I  A  L  F  N  K  L  L  D  W  F 127829 1q32.1
ARL8B
b ADP ribosylation factorlike 8B ARL10C
c ARL8B ARL10C/GIE1 NP_060654 186 M  L  A  L  I  S  R  L  L  D  W  F 55207 3p26.1
ARL9 ARL9 NP_996802 123/
265
a
M  E  F  L  E  I  G  G  S  K  /
M  E  R  G  K  V  K  K  K  E 
132946 4q12
ARL10
b ADP ribosylation factorlike 10 ARL10A
c ARL10A NP_775935 244 M  A  P  R  P  L  G  P  L  V  L  A 285598 5q35.2
ARL11 ARL11 ARL11 ARLTS1 NP_612459 196 M  G  S  V  N  S  R  G  H  K  A  E 115761 13q14.2
ARL13A
b ADP ribosylation factorlike 13A ARL13
c dJ341D10.2 NP_001013008 297 M  F  R  L  L  S  S  C  C  S  C  L 392509 Xq22.1
ARL13B
b ADP ribosylation factorlike 13B ARL2L1
c DKFZp761H079 NP_878899 428 M  F  S  L  M  A  S  C  C  G  W  F 200894 3q11.2
ARL14
b ADP ribosylation factorlike 14 ARF7
c ARL10 ARF7 NP_079323 192 M  G  S  L  G  S  K  N  P  Q  T  K 80117 3q25.33
ARL15
b ADP ribosylation factorlike 15 ARFRP2
c FLJ20051 NP_061960 204 M  S  D  L  R  I  T  E  A  F  L  Y 54622 5p15.2
ARL16
b ADP ribosylation factorlike 16 LOC339231 XP_290777 173
a M  C  L  L  L  G  A  T  G  V  G  K 339231 17q25.3
ARFRP1 ARFRP1 ARFRP1 Arp, Arp1 NP_003215 201 M  Y  T  L  L  S  G  L  Y  K  Y  M 10139 20q13.3
SAR1A
b SARA1
c SAR1A HsSara1 NP_064535 198 M  S  F  I  F  E  W  I  Y  N  G  F 56681 10q22.1
SAR1B
b SARA2
c SAR1B HsSara2 NP_057187 198 M  S  F  I  F  D  W  I  Y  S  G  F 51128 5q31.1
TRIM23 TRIM23 ARD1 (α)ARFD1, RNF46 NP_001647 574 M  A  T  L  W  N  K  L  G  A  G 373 5q12.3
Because of previous usage and to avoid confusion, the new assignments result in there being no gene/protein named ARL7 or ARL12. See Table S2 for a list of earlier names and references in 
which earlier names were used (available at http://www.jcb.org/cgi/content/full/jcb.200512057/DC1).
aThe sequence currently in the database is predicted to be incorrect, and our corrected information was used herein.
bNew names approved by the HGNC.
cPrevious names that were recently changed.
Table II.  It is expected that additional pseudogenes will be 
found and added to this list over time. We also note some uncer-
tainty as to whether ARL5C in Table I is a transcribed gene, 
as it may lack part of the consensus GTP-binding signature 
  depending on which predicted protein sequence is used.
Finally, we note that although the large majority of Arf 
family members appear to have very broad and perhaps ubiqui-
tous tissue expression patterns, a few are far more restricted in 
their expression. Thus, it is expected that further additions and 
perhaps even deletions will be needed to keep the nomenclature 
of this family current and as consistent as possible. To ensure 
that new family members are assigned unique symbols, we 
strongly encourage authors to consult the HGNC before pub-
lishing any new names for members of this gene/protein family. 
This is a confi  dential service provided by the HGNC that will 
help prevent future confusion from arising. We also suggest that 
curators and researchers focusing on other organisms use the 
information provided in this article as much as possible to sim-
plify and clarify the nomenclature across species.
Other researchers supporting the use of this nomencla-
ture include: Bruno Antonny, Bill Balch, Vytas Bankaitis, 
Gary Bokoch, Juan Bonifacino, Chris Burd, Jim Casanova, 
Tamara Caspary, Dany Cassel, Rick Cerione, Pierre Chardin, 
Philippe Chavrier, Shamshad Cockcroft, Peter Cullen, Ivan 
de Curtis, Maria Antonella De Matteis, Julie Donaldson, 
Cryslin   D’  Souza-Schorey, John Exton, Victor Faundez, Jim 
Goldenring, Jean Gruenberg, Alan Hall, Fuchu He, Wangjin 
Hong, Victor  Hsu, Mary Hunzicker-Dunn, Trevor Jackson, 
Cathy Jackson, Hans Joost, Toshi Katada, Fang-jen Lee, 
Michel Leroux, Jennifer Lippincott-Schwartz, John Logsdon, 
Alberto Luini, Vivek Malhotra, Ed Manser, Tobias Meyer, Paul 
Melancon, Joel Moss, Aki Nakano, Kazu Nakayama, Tommy 
Nilsson, Susanne Pfeffer, Richard Premont, Paul Randazzo, 
Anne Ridley, Scotty Robinson, Anne Rosenwald, Craig Roy, 
Hisataka Sabe, Randy Schekman, Nava Segev, Val Sheffi  eld, 
Phil Stahl, Elizabeth Sztul, Chris Turner, Anne Theibert, Martha 
Vaughan, Kanamarlapudi Venkateswarlu, Fred Wittinghofer, 
Keqiang Ye, and Marino Zerial.NOMENCLATURE FOR THE HUMAN ARF FAMILY • KAHN ET AL. 649
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